Metabolic Tumor Burden Predicts for Disease Progression and Death in Lung Cancer
- 1 October 2007
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 69 (2) , 328-333
- https://doi.org/10.1016/j.ijrobp.2007.04.036
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- FDG-PET maximum standardised uptake value is associated with variation in survival: Analysis of 498 lung cancer patientsLung Cancer, 2007
- Stage Is Not a Reliable Indicator of Tumor Volume in Non-small Cell Lung Cancer: A Preliminary Analysis of the Trans-Tasman Radiation Oncology Group 99-05 DatabaseJournal of Thoracic Oncology, 2006
- Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?European Journal of Nuclear Medicine and Molecular Imaging, 2005
- Diameter of Non-small Cell Lung Cancer Correlates With Long-term SurvivalChest, 2005
- The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survivalThe Journal of Thoracic and Cardiovascular Surgery, 2005
- [18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Prognostic Factors in Non-small Cell Lung CancerChest, 2002
- Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIAChest, 2000
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994